Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Take the Jonsson Cancer Center Site Survey

High Impact Publications: March 2011

The following is a list of member high impact publications for March 2011. Entries are listed by publication date, and the contributing JCCC member(s) are marked in bold.

Wasif N, Etzioni D, Maggard MA, Tomlinson JS, Ko CY. Trends, patterns, and outcomes in the management of malignant colonic polyps in the general population of the United States. Cancer. 2011 Mar 1;117(5):931-7. Epub 2009 Aug 18

Prins RM, Soto H, Konkankit V, Odesa SK, Eskin A, Yong WH, Nelson SF, Liau LM, Konkankit V. Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy. Clin Cancer Res. 2011 Mar 15;17(6):1603-15. Epub 2009 Aug 18

Ramadoss S, Li J, Ding X, Al Hezaimi K, Wang CY. Transducin ?-like protein 1 recruits nuclear factor ?B to the target gene promoter for transcriptional activation. Mol Cell Biol. 2011 Mar;31(5):924-34. Epub 2009 Aug 18

Press MF, Sauter G, Buyse M, Bernstein L, Guzman R, Santiago A, Villalobos IE, Eiermann W, Pienkowski T, Martin M, Robert N, Crown J, Bee V, Taupin H, Flom KJ, Tabah-Fisch I, Pauletti G, Lindsay MA, Riva A, Slamon DJ. Alteration of topoisomerase II-alpha gene in human breast cancer: association with responsiveness to anthracycline-based chemotherapy. J Clin Oncol. 2011 Mar 1;29(7):859-67. Epub 2009 Aug 18

Janne P, Boss DS, Camidge DR, Britten CD, Engelman JA, Garon EB, Guo F, Wong SG, Liang JQ, Letrent SP, Millham R, Taylor I, Eckhardt SG, Schellens JH, Jänne PA, Wong S, Liang J, Letrent S. Phase I dose-escalation study of the pan-HER inhibitor, PF299804, in patients with advanced malignant solid tumors. Clin Cancer Res. 2011 Mar 1;17(5):1131-9. Epub 2009 Aug 18

O'Connor OA, Pro B, Pinter-Brown L, Bartlett N, Popplewell L, Coiffier B, Jo Lechowicz M, Savage KJ, Shustov AR, Gisselbrecht C, Jacobsen E, Zinzani PL, Furman R, Goy A, Haioun C, Crump M, Zain JM, Hsi E, Boyd A, Horwitz S, Lechowicz MJ. Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study. J Clin Oncol. 2011 Mar 20;29(9):1182-9. Epub 2009 Aug 18

Ajuria L, Nieva C, Winkler C, Kuo D, Samper N, Andreu MJ, Helman A, González-Crespo S, Paroush Z, Courey AJ, Jiménez G. Capicua DNA-binding sites are general response elements for RTK signaling in Drosophila. Development. 2011 Mar;138(5):915-24. Epub 2009 Aug 18

Konecny GE, Winterhoff B, Kolarova T, Qi J, Manivong K, Dering J, Guorong E, Chalukya M, Wang HJ, Anderson L, Kalli KR, Finn RS, Ginther C, Jones S, Velculescu VE, Riehle D, Cliby WA, Randolph S, Koehler M, Hartmann LC, Slamon DJ, Yang G. Expression of p16 and retinoblastoma determines response to CDK4/6 inhibition in ovarian cancer. Clin Cancer Res. 2011 Mar 15;17(6):1591-602. Epub 2009 Aug 18

Tang ZZ, Sharma S, Zheng S, Chawla G, Nikolic J, Black DL. Regulation of the mutually exclusive exons 8a and 8 in the CaV1.2 calcium channel transcript by polypyrimidine tract-binding protein. J Biol Chem. 2011 Mar 25;286(12):10007-16. Epub 2009 Aug 18

Cao P, Xu K, Varghese JO, Heath JR. Atomic force microscopy characterization of room-temperature adlayers of small organic molecules through graphene templating. J Am Chem Soc. 2011 Mar 2;133(8):2334-7. Epub 2009 Aug 18

Ganz PA, Land SR, Geyer CE, Cecchini RS, Costantino JP, Pajon ER, Fehrenbacher L, Atkins JN, Polikoff JA, Vogel VG, Erban JK, Livingston RB, Perez EA, Mamounas EP, Wolmark N, Swain SM. Menstrual history and quality-of-life outcomes in women with node-positive breast cancer treated with adjuvant therapy on the NSABP B-30 trial. J Clin Oncol. 2011 Mar 20;29(9):1110-6. Epub 2009 Aug 18

Ganz PA, Kwan L, Stanton AL, Bower JE, Belin TR. Physical and psychosocial recovery in the year after primary treatment of breast cancer. J Clin Oncol. 2011 Mar 20;29(9):1101-9. Epub 2009 Aug 18

Choi J, Mouillesseaux K, Wang Z, Fiji HD, Kinderman SS, Otto GW, Geisler R, Kwon O, Chen JN. Aplexone targets the HMG-CoA reductase pathway and differentially regulates arteriovenous angiogenesis. Development. 2011 Mar;138(6):1173-81. Epub 2009 Aug 18

Klabunde CN, Keating NL, Potosky AL, Ambs A, He Y, Hornbrook MC, Ganz PA. A population-based assessment of specialty physician involvement in cancer clinical trials. J Natl Cancer Inst. 2011 Mar 2;103(5):384-97. Epub 2009 Aug 18

Crooks GM. Lineage assays: which pathway to take? Blood. 2011 Mar 3;117(9):2560.
Chamie K, Kurzrock EA, Evans CP, Litwin MS, Koppie TM, Wootton-Gorges SL, Boone JM, Lara PN, Devere White RW. Secondary malignancies among nonseminomatous germ cell tumor cancer survivors. Cancer. 2011 Mar 15. Epub 2009 Aug 18

Last updated: 7/29/2011 2:04:36 PM